Rajeev Raghuvanshi Appointed As New DCGI

Rajeev Raghuvanshi has been appointed as the new Drug Controller General of India (DCGI) with Appointments Committee of the Cabinet approving his appointment, as stated by an official release on February 22.

Raghuvanshi has been bestowed with DCGI charge for a span of three-year ending on February 28, 2025. He is currently the Secretary-cum-Scientific Director at Indian Pharmacopoeia Commission.

The Union Public Service Commission (UPSC) has recommended Raghuvanshi for the top post after conducting an interview of the probable candidates and assessed their profile.

UPSC had communicated to the Union health ministry about the assessment of bio data of the eligible officers and had also undergone personal interaction with the candidates on January 27. This eventually led to Dr Rajeev Singh Raghuvanshi’s appointment to the post of Drug Controller (India) by short term contract basis, they added.

The release stated that the appointment has been made in "Level 14 of the Pay Matrix", on "short term" contract basis, and with effect from the "date of his assumption of charge of the post till his attaining the age of superannuation on 28.02.2025, or until further orders, whichever is earlier".